CERUS CORP (CERS)

↓ Download CSV

CIK 0001020214 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CERUS CORP reported revenue of $233.80M, up 16.1% from the prior year. The company ran a net loss, with a net margin of -6.7%. It held $221.86M in total assets against $156.89M in total liabilities.

Key ratios (FY2025)

-3.7%
Operating margin
-6.7%
Net margin
-24.3%
Return on equity
+16.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$233.80M$201.32M$186.80M$188.31M$159.52M$114.25M$93.77M$76.05M$51.33M$39.27M
Cost of Revenue$41.16M$33.42M$31.63M$22.53M$20.30M
Gross Profit$16.89M
Operating Income-$8.68M-$14.22M-$30.05M-$34.08M-$48.94M-$58.33M-$66.23M-$54.99M-$57.53M-$61.45M
Net Income-$15.63M-$20.92M-$37.49M-$42.78M-$54.37M-$59.86M-$71.24M-$57.56M-$60.59M-$62.91M
EPS (Diluted)$-0.08$-0.11$-0.21$-0.24$-0.32$-0.37$-0.44$-0.56$-0.62
Total Assets$221.86M$200.92M$197.75M$218.09M$237.50M$221.41M$165.53M$163.46M$98.24M$103.48M
Total Liabilities$156.89M$144.02M$144.30M$149.53M$151.88M$117.61M$108.48M$78.94M$59.30M$45.69M
Shareholders' Equity$64.22M$56.15M$52.65M$67.61M$84.62M$103.81M$57.05M$84.52M$38.94M$57.79M
Cash & Equivalents$19.96M$20.27M$11.65M$35.59M$48.76M$36.59M$34.99M$28.86M$13.68M$22.56M
Operating Cash Flow$4.84M$11.36M-$43.17M-$25.61M-$33.92M-$41.81M-$65.50M-$31.25M-$52.23M-$53.53M
Capital Expenditures$3.73M$2.84M$4.60M$2.00M$910.0K$1.61M$8.94M$1.14M$353.0K$563.0K
Shares Outstanding190.59M184.56M180.27M176.54M171.28M163.95M139.83M131.66M108.22M101.83M